{"id":40762,"date":"2023-09-14T08:47:48","date_gmt":"2023-09-14T07:47:48","guid":{"rendered":"https:\/\/wames.org.uk\/cms-english\/?p=40762"},"modified":"2023-09-14T08:48:37","modified_gmt":"2023-09-14T07:48:37","slug":"depaul-symptom-questionnaire-brief-dsq-brief-a-brief-screening-scale-for-me-cfs","status":"publish","type":"post","link":"https:\/\/wames.org.uk\/cms-english\/depaul-symptom-questionnaire-brief-dsq-brief-a-brief-screening-scale-for-me-cfs\/","title":{"rendered":"DePaul Symptom Questionnaire-Brief (DSQ-Brief): a brief screening scale for ME\/CFS"},"content":{"rendered":"

A brief screening scale for ME\/CFS<\/strong><\/h2>\n

 <\/p>\n

Health professionals often use questionnaires to determine if a person has a particular illness. Prof Leonard Jason’s DePaul Symptom Questionnaire has 54 questions and takes much time and energy to get a full picture of a person’s experience of ME\/CFS.<\/p>\n

\"\"Jason and his team have now developed a short questionnaire with 4 key symptoms to screen for ME\/CFS in line with the US IOM criteria. This accurately identified people with ME\/CFS from healthy controls, but had more difficulty differentiating ME\/CFS from other chronic illnesses like MS, Long COVID and PPS.<\/p>\n

The team conclude that the DePaul Symptom Questionnaire-Brief (DSQ-Brief) is useful as a first step, but the longer questionnaire may be needed to reliably confirm ME\/CFS.<\/p>\n

<\/h3>\n

Developing and validating a brief screening scale for ME\/CFS<\/a>, by Leonard A Jason, Sage Benner, Jacob Furst & Paul Cathey, in<\/span> Fatigue: Biomedicine, Health & Behavior<\/em>, 07 Sep 2023 [doi.org\/10.1080\/21641846.2023.2252613]<\/h3>\n

Research abstract:<\/strong><\/p>\n

Objective:<\/strong>
\nThe purpose of the current study was to develop and evaluate a brief screening instrument for ME\/CFS. The current study identified 4 symptom items that identify those positive for the IOM ME\/CFS case definition.<\/a><\/p>\n

Study Design:<\/strong>
\nA data set of over 2,000 patients with Myalgic encephalomyelitis\/ chronic fatigue syndrome (ME\/CFS) and over 350 controls were assessed for the 4-item DePaul Symptom Questionnaire-Brief (DSQ-Brief). All respondents also completed the longer 54-item DePaul Symptom Questionnaire (DSQ-1)<\/a> as well as the 14-item DePaul Symptom Questionnaire-Short Form (DSQ-SF).<\/p>\n

These data sets were collected from multiple countries. We also examined the DSQ-Brief, DSQ-1, and DSQ-SF with other chronic illness groups [Multiple Sclerosis (MS) and Post-Polio Syndrome (PPS)] and those with Long COVID. Random Forest comparisons<\/a> were employed in these analyses.<\/p>\n

Results:<\/strong>
\nWhen contrasting ME\/CFS from controls, high levels of accuracy occurred using the DSQ-1, DSQ-SF, and DSQ-Brief. High accuracy again occurred for differentiating those with ME\/CFS from MS, PPS, and Long COVID using the DSQ-1 and DSQ-SF, but accuracy was less for the DSQ-Brief.<\/p>\n

Conclusions:<\/strong>
\nThe DSQ-Brief had high sensitivity, meaning it could identify those with ME\/CFS versus controls, whereas accuracy dropped with other chronic illnesses. However, it was possible to achieve better accuracy and identify those cases where misidentification occurred by administering the DSQ-SF or DSQ-1 following the DSQ-Brief. It is now possible to screen individuals for ME\/CFS using the DSQ-Brief and in so doing, identify those who are most likely to have ME\/CFS.<\/p>\n

 <\/p>\n

Image by Peggy und Marco Lachmann-Anke from Pixabay<\/h5>\n","protected":false},"excerpt":{"rendered":"

A brief screening scale for ME\/CFS   Health professionals often use questionnaires to determine if a person has a particular illness. Prof Leonard Jason’s DePaul Symptom Questionnaire has 54 questions and takes much time and energy to get a full … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[],"class_list":["post-40762","post","type-post","status-publish","format-standard","hentry","category-news"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p5qkYK-aBs","_links":{"self":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts\/40762","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/comments?post=40762"}],"version-history":[{"count":3,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts\/40762\/revisions"}],"predecessor-version":[{"id":40771,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts\/40762\/revisions\/40771"}],"wp:attachment":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/media?parent=40762"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/categories?post=40762"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/tags?post=40762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}